FDA Backs Domestic Drug Production to Counter China
The FDA has proposed policies to boost domestic drug manufacturing, including giving U.S. generic makers a patent challenge head start over foreign rivals.
3 articles tagged "Pharmaceutical Industry"
The FDA has proposed policies to boost domestic drug manufacturing, including giving U.S. generic makers a patent challenge head start over foreign rivals.
Drug manufacturers are delaying European launches as most-favored-nation pricing threatens to compress US revenues, reshaping global launch strategies in 2026.
Novo Nordisk faces shareholder scrutiny as its stock drops 45% since CEO ouster, while rival Eli Lilly surges to a $1 trillion market cap.